Desq Long
Sign in

Company

ROCKET PHARMACEUTICALS, INC.

RCKT · CIK 0001281895

SEC FORM 4
$256,463.69

ROCKET PHARMACEUTICALS, INC. (RCKT)

Sale of 75,364 shares at $3.403 per share.

Reporting Person Wilson Martin · Officer Title General Counsel · Transaction Code S

Traded Sep 11, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001140361-26-036688 · filed 2026-09-15 · View filing →

SEC FORM 4
$7,752.63

ROCKET PHARMACEUTICALS, INC. (RCKT)

Sale of 2,293 shares at $3.381 per share.

Reporting Person Shah Gaurav · Officer Title CEO · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001140361-26-033913 · filed 2026-08-20 · View filing →

SEC FORM 4
$2,133.41

ROCKET PHARMACEUTICALS, INC. (RCKT)

Sale of 631 shares at $3.381 per share.

Reporting Person Wilson Martin · Officer Title General Counsel · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001140361-26-033915 · filed 2026-08-20 · View filing →

SEC FORM 4
$11,809.83

ROCKET PHARMACEUTICALS, INC. (RCKT)

Sale of 3,493 shares at $3.381 per share.

Reporting Person Wilson Martin · Officer Title General Counsel · Transaction Code S

Traded Aug 13, 2026 · Disclosed Aug 17, 2026

Source: SEC Form 4 · 0001140361-26-033413 · filed 2026-08-17 · View filing →

SEC FORM 4
$9,591.90

ROCKET PHARMACEUTICALS, INC. (RCKT)

Sale of 2,837 shares at $3.381 per share.

Reporting Person Shah Gaurav · Officer Title CEO · Transaction Code S

Traded Aug 13, 2026 · Disclosed Aug 17, 2026

Source: SEC Form 4 · 0001140361-26-033417 · filed 2026-08-17 · View filing →

SEC FORM 4
$16,448.80

ROCKET PHARMACEUTICALS, INC. (RCKT)

Sale of 4,701 shares at $3.499 per share.

Reporting Person Chaudhuri Sarbani · Officer Title See Remarks · Transaction Code S

Traded Aug 11, 2026 · Disclosed Aug 13, 2026

Source: SEC Form 4 · 0001140361-26-032816 · filed 2026-08-13 · View filing →

SEC FORM 4
$128,266.34

ROCKET PHARMACEUTICALS, INC. (RCKT)

Sale of 36,658 shares at $3.499 per share.

Reporting Person Stevens Christopher James · Officer Title Chief Operating Officer · Transaction Code S

Traded Aug 11, 2026 · Disclosed Aug 13, 2026

Source: SEC Form 4 · 0001140361-26-032818 · filed 2026-08-13 · View filing →